Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy

Active, not recruitingOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

October 17, 2023

Study Completion Date

September 30, 2025

Conditions
Metastatic Pancreatic Cancer
Interventions
DIAGNOSTIC_TEST

Tumor DNA circulating in the bloodstream (circulating tumor DNA; ctDNA)

ctDNA will be measured at the same times as CT scans (just before the start of treatment, as well as 2 months after), and the response measured by the ctDNA change will be compared to the response seen on the changes between the CT scans. The goal is to make sure that ctDNA response correlates well with CT scan response measurement.

Trial Locations (1)

11042

Zuckerberg Cancer Center, New Hyde Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER